APRE icon

Aprea Therapeutics
APRE

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$5.5
504% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Wedbush
Wedbush
Robert Driscoll
100% 1-yr APRE win rate
10 Feb ‘26 22 days ago
HC Wainwright & Co
HC Wainwright & Co
Joseph Pantginis
50% 1-yr APRE win rate
29 Jan ‘26 1 month ago